申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160272621A1
公开(公告)日:2016-09-22
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.
本发明涉及公式I的化合物及其盐,以及使用这些化合物治疗与GSK-3相关的疾病的组合物和方法。